(Q44796472)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Timos Vyzantiadis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sofia Vakalopoulou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Konstantinos Tziomalos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Vasilia Garypidou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Miranta Athanassiou-Metaxa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Fedon Harsoulis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

91-2; author reply 93-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15015977%20AND%20SRC:MED&resulttype=core&format=json

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04871.X

Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04871.X

Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04871.X

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04871.X

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04871.X

Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04871.X